Collplant Biotechnologies Ltd
CLGN
Revenue
249.00k
▼-9.94M▼-97.55%
12 Months ChangeAssets
34.08M
▲11.23M▲49.17%
6 Months ChangeLiabilities
16.16M
▲6.25M▲63.01%
6 Months ChangeFree Cash Flow
-5.50M
▼-5.50M0.00%
-Revenue/Cost Of Revenue
Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Cost Of Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Revenue
Cost Of Revenue
No Data
Date | Revenue | Cost Of Revenue |
---|---|---|
No Data |
Net Profit/Loss
Net Profit/Loss
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Net Profit/Loss
Baseline
No Data
Date | Net Profit/Loss |
---|---|
No Data |
Assets/Liabilities
Assets
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Liabilities
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Assets
Liabilities
No Data
Date | Assets | Liabilities |
---|---|---|
No Data |
Cash Flows
Operating (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Investing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Financing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Free Cash Flow
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
No Data
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
No Data |
EPS
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
EPS (Diluted)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
EPS
EPS (Diluted)
No Data
Date | EPS | EPS (Diluted) |
---|---|---|
No Data |
Outstanding Shares
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Outstanding Shares
No Data
Date | Outstanding Shares |
---|---|
No Data |
Recent Quarterly and Annual Filings
2024-04-04
Form 20-F
ID: 0001213900-24-030055
2023-03-29
Form 20-F
ID: 0001213900-23-023849
2022-03-24
Form 20-F
ID: 0001213900-22-014666
2021-03-26
Form 20-F
ID: 0001213900-21-017883
2020-04-01
Form 20-F
ID: 0001213900-20-008285
2019-04-01
Form 20-F
ID: 0001213900-19-005360
2018-03-20
Form 20-F
ID: 0001213900-18-003218